Zochling J - Search Results

1

A retrospective chart review of the use of rituximab for the treatment of rheumatoid arthritis in Australian rheumatology practice.

Nicholls D, Zochling J, Boers A, Champion G, Mathers D, Riordan J, Youssef P, Scott J, Griffiths H. Nicholls D, et al. Among authors: zochling j. Int J Rheum Dis. 2014 Sep;17(7):755-61. doi: 10.1111/1756-185X.12164. Epub 2013 Oct 16. Int J Rheum Dis. 2014. PMID: 24131467

2

A multi-center, observational study shows high proportion of Australian rheumatoid arthritis patients have inadequate disease control.

Littlejohn G, Roberts L, Arnold M, Bird P, Burnet S, de Jager J, Griffiths H, Nicholls D, Scott J, Zochling J, Tymms KE. Littlejohn G, et al. Among authors: zochling j. Int J Rheum Dis. 2013 Oct;16(5):532-8. doi: 10.1111/1756-185X.12163. Int J Rheum Dis. 2013. PMID: 24164840

3

Patients with Rheumatoid Arthritis in the Australian OPAL Cohort Show Significant Improvement in Disease Activity over 5 Years: A Multicenter Observational Study.

Littlejohn G, Roberts L, Bird P, de Jager J, Griffiths H, Nicholls D, Young J, Zochling J, Tymms KE. Littlejohn G, et al. Among authors: zochling j. J Rheumatol. 2015 Sep;42(9):1603-9. doi: 10.3899/jrheum.141575. Epub 2015 Jul 1. J Rheumatol. 2015. PMID: 26136482

4

Psoriatic arthritis treatment regimens, therapy duration and reasons for cessation in the biologics era: a multi-centre Australian study.

Tymms K, Kelly A, Bird P, Griffiths H, de Jager J, Littlejohn G, Louw S, Roberts L, Youssef P, Zochling J, Nichols D. Tymms K, et al. Among authors: zochling j. Int J Rheum Dis. 2018 Feb;21(2):510-516. doi: 10.1111/1756-185X.13127. Epub 2017 Jul 21. Int J Rheum Dis. 2018. PMID: 28730757

5

The CEDAR Study: A Longitudinal Study of the Clinical Effects of Conventional DMARDs and Biologic DMARDs in Australian Rheumatology Practice.

Roberts L, Tymms K, de Jager J, Littlejohn G, Griffiths H, Nicholls D, Bird P, Young J, Hill J, Zochling J. Roberts L, et al. Among authors: zochling j. Int J Rheumatol. 2017;2017:1201450. doi: 10.1155/2017/1201450. Epub 2017 May 23. Int J Rheumatol. 2017. PMID: 28630629 Free PMC article.

6

Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity.

Tymms K, Zochling J, Scott J, Bird P, Burnet S, de Jager J, Griffiths H, Nicholls D, Roberts L, Arnold M, Littlejohn G. Tymms K, et al. Among authors: zochling j. Arthritis Care Res (Hoboken). 2014 Feb;66(2):190-6. doi: 10.1002/acr.22108. Arthritis Care Res (Hoboken). 2014. PMID: 23983001 Free article.

7

The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.

Bird P, Griffiths H, Tymms K, Nicholls D, Roberts L, Arnold M, Burnet S, de Jager J, Scott J, Zochling J, Littlejohn G. Bird P, et al. Among authors: zochling j. J Rheumatol. 2013 Mar;40(3):228-35. doi: 10.3899/jrheum.120922. Epub 2013 Jan 15. J Rheumatol. 2013. PMID: 23322457

8

Australian and New Zealand national evidence-based recommendations for the investigation and follow-up of undifferentiated peripheral inflammatory arthritis: an integration of systematic literature research and rheumatological expert opinion.

Barrett C, Bird P, Major G, Romas E, Portek I, Taylor A, Zochling J; Australian and New Zealand 3e Group. Barrett C, et al. Among authors: zochling j. Int J Rheum Dis. 2013 Dec;16(6):637-51. doi: 10.1111/1756-185X.12189. Epub 2013 Oct 16. Int J Rheum Dis. 2013. PMID: 24131599 Review.

9

Australian and New Zealand evidence-based recommendations for pain management by pharmacotherapy in adult patients with inflammatory arthritis.

Richards BL, Whittle S, Buchbinder R, Barrett C, Lynch N, Major G, Littlejohn G, Taylor A, Zochling J; Australia 3e Scientfic Committee; New Zealand 3e Scientific Committee. Richards BL, et al. Among authors: zochling j. Int J Rheum Dis. 2014 Sep;17(7):738-48. doi: 10.1111/1756-185X.12388. Epub 2014 May 30. Int J Rheum Dis. 2014. PMID: 24889411 Review.

10

The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.

Thakkar V, Stevens W, Prior D, Rabusa C, Sahhar J, Walker JG, Roddy J, Lester S, Rischmueller M, Zochling J, Nash P, Gabbay E, Youssef P, Proudman SM, Nikpour M. Thakkar V, et al. Among authors: zochling j. Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):129-136. Epub 2016 May 23. Clin Exp Rheumatol. 2016. PMID: 27214686

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page